Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $127,968 - $144,122
-930 Reduced 73.17%
341 $52.8 Million
Q1 2023

May 28, 2024

SELL
$144.61 - $166.54 $196,524 - $226,327
-1,359 Closed
0 $0
Q4 2022

May 28, 2024

BUY
$138.31 - $165.87 $187,963 - $225,417
1,359 New
1,359 $219,000
Q3 2022

May 28, 2024

SELL
$134.21 - $153.93 $109,515 - $125,606
-816 Closed
0 $0
Q2 2022

May 28, 2024

SELL
$137.62 - $174.96 $30,551 - $38,841
-222 Reduced 21.39%
816 $124,000
Q1 2022

May 28, 2024

BUY
$131.98 - $163.75 $136,995 - $169,972
1,038 New
1,038 $168,000
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $10,313 - $13,049
96 Added 8.17%
1,271 $172,000
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $532 - $603
5 Added 0.43%
1,175 $126,000
Q2 2021

Aug 05, 2021

BUY
$105.21 - $117.21 $7,364 - $8,204
70 Added 6.36%
1,170 $132,000
Q1 2021

May 20, 2021

SELL
$102.3 - $112.62 $1,125 - $1,238
-11 Reduced 0.99%
1,100 $119,000
Q4 2020

Mar 04, 2021

BUY
$80.49 - $108.67 $40,727 - $54,987
506 Added 83.64%
1,111 $119,000
Q3 2020

Nov 03, 2020

SELL
$85.91 - $100.83 $10,738 - $12,603
-125 Reduced 17.12%
605 $53,000
Q2 2020

Aug 20, 2020

BUY
$73.37 - $98.18 $53,560 - $71,671
730 New
730 $72,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Rockbridge Investment Management, Lcc Portfolio

Follow Rockbridge Investment Management, Lcc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockbridge Investment Management, Lcc, based on Form 13F filings with the SEC.

News

Stay updated on Rockbridge Investment Management, Lcc with notifications on news.